Biotech M&A Anomalies With Allan Shaw
Business Of Biotech
00:00
Are You a Preclinical Company That Shouldn't Be Around?
I think investors are really starting to discern going through the rubble right now. Having something that's proof of human proof of concept is important. But not having a runway puts you in a very uncomfortable position too. And I think there are a lot of people or companies that have found themselves bridged to nowhere.
Transcript
Play full episode
